Tom Greene

Professor

University of Utah

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Tom Greene is a Professor at the University of Utah, United States. His research focuses on chronic kidney disease, antibiotic therapy for pneumonia, and the effects of diabetes medications on renal outcomes. He has contributed to various studies, including clinical trials and implementation protocols aimed at improving health outcomes in renal and cardiovascular diseases.

Articles (9)

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Oleksandr Bilchenko

UKRAINE

View details

Chelsey Schlechter

Assistant Professor

University of Utah

UNITED STATES

View details

Bryan Gibson

Assistant Professor

University of Utah

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tom Greene

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

QuitSMART Utah: An implementation study protocol for a cluster-randomized, multi-level Sequential Multiple Assignment Randomized Trial to increase Reach and Impact of tobacco cessation treatment in Community Health Centers

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial

Measured and estimated glomerular filtration rate: current status and future directions

Rationale and protocol of the Dapagliflozin and Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Should You Follow the Better-Hearing Ear for Congenital Cytomegalovirus Infection and Isolated Sensorineural Hearing Loss?

Sodium bicarbonate supplementation and urinary TGF-β1 in nonacidotic diabetic kidney disease a randomized, controlled trial

Unilateral versus bilateral hilar stents for the treatment of cholangiocarcinoma: A multicenter international study

Collaborators (3)

Oleksandr Bilchenko

Chelsey Schlechter

Bryan Gibson

Make your next move.

Tom Greene

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

QuitSMART Utah: An implementation study protocol for a cluster-randomized, multi-level Sequential Multiple Assignment Randomized Trial to increase Reach and Impact of tobacco cessation treatment in Community Health Centers

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c &lt;7%: Results From the CREDENCE Trial

Measured and estimated glomerular filtration rate: current status and future directions

Rationale and protocol of the Dapagliflozin and Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Should You Follow the Better-Hearing Ear for Congenital Cytomegalovirus Infection and Isolated Sensorineural Hearing Loss?

Sodium bicarbonate supplementation and urinary TGF-β1 in nonacidotic diabetic kidney disease a randomized, controlled trial

Unilateral versus bilateral hilar stents for the treatment of cholangiocarcinoma: A multicenter international study

Collaborators (3)

Oleksandr Bilchenko

Chelsey Schlechter

Bryan Gibson

Make your next move.

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial